West Pharmaceutical Services, Inc. (WST)

Market Cap	19.11B +15.6%
Revenue (ttm)	3.07B +6.3%
Net Income	493.70M +0.2%
EPS	6.79 +1.5%
Shares Out	72.02M
PE Ratio	38.99
Forward PE	33.02
Dividend	$0.88 (0.33%)
Ex-Dividend Date	Apr 29, 2026

Volume	243,501
Open	262.76
Previous Close	259.35
Day's Range	262.03 - 266.65
52-Week Range	187.43 - 322.34
Beta	1.15
Analysts	Buy
Price Target	319.43 (+20.4%)
Earnings Date	Apr 23, 2026

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,800
• Stock Exchange: NYSE
• Ticker Symbol: WST
• Website: https://www.westpharma.com

Financial Performance

In 2025, WST's revenue was $3.07 billion, an increase of 6.25% compared to the previous year's $2.89 billion. Earnings were $493.70 million, an increase of 0.20%.

Analyst Summary

According to 7 analysts, the average rating for WST stock is "Buy." The 12-month stock price target is $319.43, which is an increase of 20.40% from the latest price.

Price Target

$319.43

(20.40% upside)

Analyst Consensus: Buy